Targeting NSCLC with Precision: Evaluation of the Emerging Role of Antibody-Drug Conjugates : Episode 12
Opinion
Video
Key Takeaways from TROPION Trials: Implications for NSCLC Treatment Landscape
Author(s):
1. Please review recently presented data from the TROPION trial series investigating Dato-DXd in patients with previously treated NSCLC. Briefly outline the design and key endpoints for these studies. What are some key takeaways from these data and what implications may findings have the treatment landscape?
Related Videos
Related Content
